CoreCap Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$853K Sell
3,863
-352
-8% -$97.4K 0.03% 413
2026
Q1
$1.25M Buy
4,215
+641
+18% +$190K 0.04% 324
2025
Q4
$976K Buy
3,574
+210
+6% +$57.1K 0.03% 375
2025
Q3
$909K Sell
3,364
-2,689
-44% -$732K 0.03% 394
2025
Q2
$1.67M Buy
6,053
+2,887
+91% +$785K 0.07% 241
2025
Q1
$840K Buy
3,166
+170
+6% +$41.9K 0.04% 368
2024
Q4
$696K Buy
2,996
+399
+15% +$91.8K 0.03% 403
2024
Q3
$573K Buy
2,597
+587
+29% +$121K 0.03% 437
2024
Q2
$395K Buy
2,010
+347
+21% +$71.7K 0.04% 260
2024
Q1
$358K Buy
1,663
+355
+27% +$74.6K 0.02% 466
2023
Q4
$275K Buy
+1,308
New +$279K 0.02% 483
2022
Q4
$26.5K Buy
+157
New +$27.3K ﹤0.01% 1198
2022
Q3
Sell
-88
Closed -$18K 807
2022
Q2
$18K Buy
+88
New +$18.7K ﹤0.01% 1271
2022
Q1
Sell
-88
Closed -$20K 822
2021
Q4
$20K Buy
+88
New +$19.4K ﹤0.01% 1323

Other funds holding CME

CoreCap Advisors's CME Position: Q2 2026 in Review

CoreCap Advisors reduced its CME Group (CME) stake by 8.4% in Q2 2026, selling an estimated $97.4K and leaving 3,863 shares worth $853K. The position accounts for 0.03% of the portfolio, ranked #413.

CoreCap Advisors first reported a position in CME in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.67M in Q2 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • CoreCap Advisors held 3,863 shares of CME Group worth $853K as of Q2 2026.
  • CoreCap Advisors sold 352 CME Group shares in Q2 2026, an estimated $97.4K.
  • CME Group made up 0.03% of CoreCap Advisors's portfolio in Q2 2026, its #413 holding.
  • CoreCap Advisors first reported a position in CME Group in Q4 2021 and has held it in 14 quarters since.
  • CoreCap Advisors's CME Group position peaked at $1.67M in Q2 2025.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.